ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,765,000 | +52.9% | 141,892 | +68.3% | 0.00% | 0.0% |
Q3 2016 | $1,154,000 | +113.3% | 84,296 | +15.1% | 0.00% | +100.0% |
Q2 2016 | $541,000 | +26.1% | 73,249 | +9.2% | 0.00% | 0.0% |
Q1 2016 | $429,000 | -34.6% | 67,094 | -36.1% | 0.00% | 0.0% |
Q4 2015 | $656,000 | -72.1% | 104,995 | -73.9% | 0.00% | -80.0% |
Q3 2015 | $2,352,000 | -30.7% | 402,812 | -1.8% | 0.01% | -28.6% |
Q2 2015 | $3,393,000 | -26.6% | 410,278 | -26.9% | 0.01% | -22.2% |
Q1 2015 | $4,625,000 | +20.3% | 561,274 | +0.3% | 0.01% | +12.5% |
Q4 2014 | $3,845,000 | +21.6% | 559,620 | -4.5% | 0.01% | +14.3% |
Q3 2014 | $3,163,000 | -8.9% | 585,741 | +7.4% | 0.01% | -12.5% |
Q2 2014 | $3,473,000 | -13.0% | 545,255 | +10.1% | 0.01% | -11.1% |
Q1 2014 | $3,991,000 | +21.9% | 495,164 | +3.1% | 0.01% | +12.5% |
Q4 2013 | $3,275,000 | +181.1% | 480,268 | +658.3% | 0.01% | +166.7% |
Q3 2013 | $1,165,000 | +35.6% | 63,333 | +29.0% | 0.00% | 0.0% |
Q2 2013 | $859,000 | – | 49,088 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
Geduld E E | 120,100 | $767,000 | 1.05% |
JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |